Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Adds Strong Warnings To Anti-Smoking Drug Labels
"The Food and Drug Administration announced that it is requiring the smoking-cessation drugs Chantix and Zyban to carry the strongest type of safety warning possible to alert patients that the medications can cause serious mental health problems, including depression and suicide," the Washington Post reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
